Chemodex

Moxidectin

CHF 102.00
In stock
CDX-M0188-M02525 mgCHF 102.00
More Information
Product Details
Synonyms 23-Methoxime-LL-F 28249α; CL 301423
Product Type Chemical
Properties
Formula

C37H53NO8

MW 639.82
CAS 113507-06-5
RTECS PY5438800
Source/Host Chemicals Semisynthetic
Purity Chemicals EP
Appearance Yellow powder.
Solubility Soluble in DMSO, ethanol or DMF (all 20mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key YZBLFMPOMVTDJY-LSGXYNIPSA-N
Smiles O[C@]1([C@](C=C2C)([H])C(O[C@](C3)([H])C4)=O)[C@]([C@@H]2O)([H])OC/C1=C\C=C\[C@H](C)C/C(C)=C/C[C@@]3([H])O[C@]4(C/5)O[C@H](/C(C)=C/C(C)C)[C@@H](C)C5=N\OC
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Moxidectin is broad-spectrum antiparasitic agent used in animals to prevent or control parasitic worms (helminths), such as heartworm and intestinal worms, in dogs, cats, horses, cattle and sheep. Moxidectin kills some of the most common internal and external parasites by selectively binding to a parasite's glutamate-gated chloride ion channels. These channels are vital to the function of invertebrate nerve and muscle cells. When moxidectin binds to the channels, it disrupts neurotransmission, resulting in paralysis and death of the parasite. Moxidectin selectively enhanced the tonic GABA conductance of hippocampal pyramidal neurons in rats. Moxidectin is also used in the treatment of onchocerciasis, against acaricides/miticides, as well as in the prevention and treatment of other parasitic infections in veterinary medicine. Moxidectin belongs to the milbemycin familyand is similar to avermectins in terms of chemical strucutre. It might have some antitumor and multidrug resistance properties.

Product References

(1) S. Ranjan, et al.; Vet. Parasitol. 41, 227 (1992) | (2) C. Menez, et al.; PLoS Negl. Trop. Dis. 6, e1883 (2012) | (3) J. Spampanato, et al.; J. Neurophysiol. 119, 1693 (2018) | (4) D. Song, et al.; Oncol. Rep. 40, 1348 (2018) | (5) B. Getachew & Y. Tizabi; Behav. Brain Res. 376, 112220 (2019) | (6) M. Sharaf, et al.; Exp. Parasitol. (epub ahead of print) (2020)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.